DouglasFrancisBeachMD
Oncology • Philadelphia, PAHematologic Oncology
Associate Program Director of Internal Medicine Residency at Pennsylvania Hospital; Clinical Assistant Professor, University of Pennsylvania; Director of CREP/Breast and Ovarian Cancer Program at Pennsylvania Hospital
Dr. Beach is on Doximity
As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
230 W Washington Sq
2nd Floor
Philadelphia, PA 19106Phone(215) 829-6088
- Is this information wrong?
Education & Training
Cooper University HospitalFellowship, Hematology/Oncology, 2009 - 2012
Cooper University HospitalResidency, Internal Medicine, 2006 - 2009
Rutgers Robert Wood Johnson Medical SchoolClass of 2006
Certifications & Licensure
PA State Medical License 2011 - 2022
NJ State Medical License 2009 - 2021- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Study to Assess the Efficacy and Safety of Ublituximab + TGR-1202 With or Without Bendamustine and TGR-1202 Alone in Patients With Previously Treated Non-Hodgkins Lymphoma Start of enrollment: 2016 Jun 01Owen A O'Connor, MD, PhD
- Ublituximab + TGR-1202 Compared to Obinutuzumab + Chlorambucil in Patients With Untreated and Previously Treated Chronic Lymphocytic Leukemia Start of enrollment: 2016 Jan 01
- A Pilot Trial of AVD and Brentuximab Vedotin (SGN-35) in the Treatment of Stage III-IV HIV-associated Hodgkin Lymphoma Start of enrollment: 2015 Jun 01Caroline Besson, MD and Nicolas Mounier, Pr
- Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Start of enrollment: 2012 Jul 01Lee Ratner, MD, PhD
- Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Lakshmi Rajdev
- Ibrutinib, Rituximab, Etoposide, Prednisone, Vincristine Sulfate, Cyclophosphamide, and Doxorubicin Hydrochloride in Treating Patients With HIV-Positive Stage II-IV Diffuse Large B-Cell Lymphomas Ida Wong-Sefidan
Publications & Presentations
PubMed
- Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial.Mato, A. R.,Roeker, L. E.,Allan, J. N.,Pagel, J. M.,Brander, D. M.,Hill, B. T.,Cheson, B. D.,Furman, R. R.,Lamanna, N.,Tam, C. S.,Handunnetti, S.,Jacobs, R.,Lansigan, ...> ;Am. J. Hematol.. 2018 Aug 23
- On the generalizability of prostate cancer studies: why race matters.Oren O, Oren M, Beach D> ;Ann Oncol. 2016 Dec
- Superior vena cava syndrome as an initial presentation of low-grade follicular lymphoma.Grant S, Meykler S, Beach D> ;J Community Support Oncol. 2014 Nov
- Join now to see all
Press Mentions
Beach-Rak Medicine LLC Debuts Its First App of the MD SeriesFebruary 24, 2018 11:00
Hospital Affiliations
Pennsylvania HospitalPhiladelphia, Pennsylvania
Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
